Kuraray Co., Ltd. Strategy, SWOT and Corporate Finance Report Prices from USD $175

04:48 EST 2 Dec 2016 | BioPortfolio Reports

Kuraray Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Findings
Detailed information on Kuraray Co., Ltd. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Kuraray Co., Ltd. in the form of a SWOT analysis
An indepth view of the business model of Kuraray Co., Ltd. including a breakdown and examination of key business segments
Intelligence on Kuraray Co., Ltd.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Kuraray Co., Ltd., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Gain understanding of Kuraray Co., Ltd. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Kuraray Co., Ltd. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Kuraray Co., Ltd.'s business structure, strategy and prospects

Key Highlights
Kuraray Co., Ltd. Kuraray or 'the group' is engaged in the manufacturing of chemical products, resins, fibers, high performance material and medical products. The group primarily operates in Asia, North America and Europe. It is headquartered in Osaka, Japan, and employed 8,405 people as of December 31, 2015.

Original Article: Kuraray Co., Ltd. Strategy, SWOT and Corporate Finance Report Prices from USD $175


More From BioPortfolio on "Kuraray Co., Ltd. Strategy, SWOT and Corporate Finance Report Prices from USD $175"

Quick Search

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...